Home › Pulmonary Hypertension › Oklahoma › Tulsa
Pulmonary Hypertension clinical trials in Tulsa, OK
3 studies for Pulmonary Hypertension are looking for participants at sites in and around Tulsa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Recruiting
- Oklahoma Heart Institute, Tulsa
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Oklahoma Heart Institute, Tulsa
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- Oklahoma Heart Institute at Utica, Tulsa
- Saint Francis Hospital, Tulsa
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA10 studies
- Phoenix, AZ9 studies
- Aurora, CO9 studies
- Kansas City, KS8 studies
- New York City, NY8 studies
- Cincinnati, OH8 studies
- Boston, MA8 studies
- Indianapolis, IN8 studies
- Bend, OR7 studies
- Salt Lake City, UT7 studies
- Houston, TX7 studies
- Rochester, MN7 studies
Other studies in Tulsa
- Heart Failure10 studies
- Overweight6 studies
- Obesity5 studies
- Melanoma5 studies
- Ischemic Stroke5 studies
- COPD4 studies
- Parkinson's Disease4 studies
- Aortic Valve Stenosis4 studies
- Cervical Cancer4 studies
- Breast Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Ovarian Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.